Privately held Pear Therapeutics said the company raised $64 million from investors, including Singapore’s Temasek Holdings, weeks after launching a mobile app for treating patients with substance use disorder.
The FDA cleared Pear Therapeutics’ app to help increase retention of patients undergoing outpatient treatment for opioid abuse.
For a while now there has been a heated debate surrounding hybrid and closed loop insulin systems.
Personalized medicine continues to grow in importance, and having the ability to monitor health data has proven to be a significant desire for people as the number of wearable devices continues to grow.
People who have trouble falling asleep and staying asleep may want to seek advice from a doctor and avoid long-term use of sleeping pills, medical experts advise.
23andMe will no longer provide “outside app developers” access to the company’s raw genetic data, CNBC reported.
In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.
Novartis launched its Galaxies of Hope app, a unique digital experience created to support the neuroendocrine tumor community.
AstraZeneca’s new drugs performed strongly in second-quarter 2018, offering a glimpse of better times ahead as the company struggles with falling sales of the cholesterol fighter Crestor due to generic competition.
A new study published in Scientific Reports found Noom Coach users who lived in colder temperatures were most successful at losing weight.